参考文献/References:
[1] PANDEY AN.Retinoblastoma:an overview[J].Saudi Ophthalmol,2014,28(4):310-315.
[2] RODRIGUEZ-GALINDO C,ORBACH DB,VANDERVEEN D.Retinoblastoma[J].Pediatr Clin North Am,2015,62(1):201-223.
[3] ABRAMSON DH.Retinoblastoma:Siving life with vision[J].Annu Rev Med,2014,65(1):171-184.
[4] ASNAGHI L,TRIPATHY A,YANG Q,KAUR H,HANAFORD A.Targeting Notch signaling as a novel therapy for retinoblastoma[J].Oncotarget,2016,7(43):70028-70044.
[5] DIMARAS H,KIMANI K,DIMBA EA,GRONSDAHL P,WHITE A,CHAN HS,et al.Retinoblastoma[J].Lancet,2012,379(9824):1436-1446.
[6] PARULEKAR MV.Retinoblastoma:current treatment and future direction[J].Early Hklm Dev,2010,86(10):619-625.
[7] CAROL L,SHIELDS CL,MASHAYEKHI A,AU AK,CRAIG CZYZ,ANN LEAHEY,et al.The international classification of retinoblastoma prediets chemoreduction success[J].Ophthalmology,2006,113(12):2276-2280.
[8] WYSE E,HANDA JT,FRIENDMAN AD,MS PEARL.A review of the literature for intra-arterial chemotherapy used to treat retinoblastoma[J].Pediatr Radiol,2016,46(9):1223-1233.
[9] MUEN WJ,KINGSTON JE,ROBERTSON F,REDDY M,BREW S,SAGOO MS,et al.Efficacy and complications of super-selective intra-ophthalmic artery melphalan for the treatment of refractory retinoblastoma[J].Ophthalmology,2012,119(3):611-616.
[10] ABRAMSON DH,DUNKEL IJ,BRODIE SE,MARR B,GOBIN YP.Supers elective ophthalmic artery chemotherapy as primary treatment for retinoblastoma(chemosurgery)[J].Ophthalmology,2010,117(8):1623-1629.
[11] REESE AB,HYMAN GA,TAPLEY ND,FORREST AW.The treatment of retinoblastoma by x-ray and triethylene melamine[J].Arch Ophthalmol,1958,60(5):897-906.
[12] KIRIBUEHI M,HASEGAWA.Retrograde infusion of anti-cancer drugs to ophthalmic artery for intraocular malignant tumors[J].Iryo,1968,22(7):772.
[13] YAMANE T,KANEKO A,MOHRI M.The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma[J].Int J Clin Oneol,2004,9(2):69-73.
[14] ABRAMSON DH,DUNKEL IJ,BRODIE SE,KIM JW,GOBIN YP.A phase I/II study of direct intraarterial ophthalmic artery chemotherapy with melphalan for intraocular retinoblastoma initial results[J].Ophthalmology,2008,115(8):1398-1404.
[15] LUMBROSO-LE ROUIC L,AERTS I,LEVY-GABRIEL C,DENDALE R,SASTRE X.Conservative treatments of intraocular retinoblastoma[J].Ophthalmology,2008,115(8):1405-1410.
[16] COHEN VML,KINGSTOMN J,HUNGERFORD JL.The success of primary chemotherapy for group D heritable retinoblastoma[J].Br J Ophthalmol,2009,93(7):887-890.
[17] SHIELDS CL,MANJANDAVIDA FP,LALLY SE,PIERETTI G,AREPALLI SA,CAYWOOD EH,et al.Intra-arterial chemotherapy for retinoblastoma in 70 eyes:outcomes based on the international classification of retinoblastoma[J].Ophthalmology,2014,121(7):1453-1460.
[18] SHIELDS CL,BIANCIOTTO CG,JABBOUR P,GRIFFIN GC,RAMASUBRAMANIAN A,ROSENWASSER R,et al.Intra-arterial chemotherapy for retinoblastoma:report No.1,control of retinal tumors,subretinal seeds and vitreous seeds[J].Arch Ophthalmol,2011,129(11):1399-1406.
[19] CAROL L,SHIELDS CL,KALIKI S,JABBOUR P,GRIFFIN GC,SHIELDS JA,et al.Minimal exposure(one or two cycles) of intra-arterial chemotherapy in the management of retinoblastoma[J].Ophthalmology,2012,119(5):188-192.
[20] ONG SJ,CHAO AN,WONG HF,LIOU KL,KAO LY.Selective ophthalmic arterial injection of melphalan for intraocular retinoblastoma:a 4-year review[J].Jpn J Ophthalmol,2015,59(2):109-117.
[21] PETERSON EC,ELHAMMADY MS,QUINTERO-WOLFE S,MURRAY TG,AZIZSULTAN MA.Selective ophthalmic artery infusion of chemotherapy for advanced intraocular retinoblastoma:initial experience with 17 tumors[J].J Neurosurg,2011,114(6):1603-1608.
[22] SHIELDS CL,SAY EA,CAO C,POINTDUJOUR-LIM R,JABBOUR PM,SHIELDS JA,et al.Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy[J].J Franc Dophtalmol,2015,38(6):542-549.
[23] JI XD,LI JK,ZHAO JY,ZHANG J,HUA XM,ZHAO PQ,et al.Efficacy of intra-arterial chemotherapy for advanced retinoblastoma after failure of intravenous chemotherapy[J].Chin J Ocul Fund Diss,2015,31(6):556-559.
季迅达,李家恺,赵军阳,张靖,华续明,赵培泉,等.眼内晚期视网膜母细胞瘤静脉化学治疗失败后行眼动脉介入化学治疗的疗效观察[J].中华眼底病杂志,2015,31(6):556-559.
[24] GOBIN YP,DUNKEL IJ,MARR BP,BRODIE SE,ABRAMSON DH.Intra-arterial chemotherapy for the management of retinoblastoma:four-year experience[J].Arch Ophthalmol,2011,129(6):732-737.
[25] ABRAMSON DH,Marr BP,Dunkel IJ,BRODIE SE,ZABOR EC,DRISCOLL SJ,et al.Intra-arterial chemotherapy for retinoblastoma in eyes with vitreous and/or subretinal seeding:2-year results[J].Br J Ophthalmol,2012,96(4):499-502.
[26] FRANCIS JH,ABRAMSON DH,GOBIN YP,MARR BP,TENDLER L,BRODIE SE,et al.Efficacy and toxicity of second-course ophthalmic artery chemosurgery for retinoblastoma[J].Ophthalmology,2015,122(5):1016-1022.
[27] CHEN M,ZHAO J,XIA J,LIU Z,JIANG H,SHEN G,et al.Intra-arterial chemothpherapy as primary therapy for retinoblastoma in infants less than 3 months of age:a series of 10 case-studies[J].PLoS One,2016,11(8):e0160873.
[28] SHIELDS CL,LALLY SE,LEAHEY AM,JABBOUR PM,CAYWOOD EH,SCHWENDEMAN R,et al.Targeted retinoblastoma management:when to use intravenous,intra-arterial,periocular,and intravitreal chemotherapy[J].Curr Opin Ophthalmol,2014,25(5):374-385.
[29] BIANTIOTTO C,SHIELDS CL,HURRALDE JC,SALICI A,JABBOUR PM,SHIELDS JA.Fluorescein angiographic findings after intra-arterial chemotherapy for retinoblastoma[J].Ophthalmology,2012,119(4):843-849.
[30] ABRAMSON DH,MARR BP,BRODIE SE,DUNKEL IJ,LIN A,FOLBERG R,et al.Intraocular hemorrhage after intra-arterial chemotherapy for retinoblastoma in sickle cell trait[J].Open Ophthalmol J,2012,6(1):1-3.
[31] SAMURAY T,SERRA S,REJIN K,TANYILDIZ B,CEBECI Z,AYDIN K.Superselective intra-arterial chemotherapy in the primary management of advanced intra-ocular retinoblastoma:first 4-year experience from a single institution in Turkey[J].Acta Ophthalmol,2016,94(7):e644-e651.
[32] FRANSIS JH,ABRAMSON DH.Recent advances in retinoblastoma treatment[M].Bolin:Springer International Publishing,2015:27-36.
[33] SHIELDS CL,BIANCIOTTO CG,JABBOUR P,GRIFFIN GC,RAMASUBRAMANIAN A,ROSENWASSER R,et al.Intra-arterial chemotherapy for retinoblastoma:report No2,treatment complications[J].Arch Ophthalmol,2011,129(11):1407-1415.
[34] DE IHI,SEIDER MI,HETTSDELAYED SW.Cerebral Infarction Following Intra-arterial Chemotherapy for Retinoblastoma[J].JAMA Ophthalmol,2016,134(6):712.
[35] ORCABH DB,VENDEVEEN DK,CARLOS RODRIGUEZ-GALINDO,SHAR AS.Blue toe syndrome:a complication of intra-arterial technique,not intra-arterial chemotherapy for retinoblastoma[J].JAMA Ophthalmol,2014,132(5):654-655.
[36] VIJAYAKRISHNAN R,SHIELDS CL,RAMASUBRAMANIAN A,EMRICH J,ROSENWASSER R,SHIELDS JA.Irradiation toxic effects during intra-arterial chemotherapy for retinoblastoma:should we be concerned[J].Arch Ophthalmol,2010,128(11):1427-1431.
[37] JABBOUR P,CHALOUHI N,TJOUMAKARIS S,GONZALEZ LF,DUMONT AS,CHITILE R,et al.Pearls and pitfalls of intraarterial chemotherapy for retinoblastoma[J].J Neurosurg Pediatr,2012,10(3):175-181.
[38] ABRAMSON DH,SHIELDS CL,Munier FL,CHANTADA GL.Treatment of retinoblastoma in 2015:agreement and disagreement[J].JAMA Ophthalmol,2015,133(11):1341-1347.
[39] YOUSEF YA,SOLIMAN SE,ASTUDILLO PP.Intra-arterial chemotherapy for retinoblastoma:a systematic review[J].Ophthalmology,2012,119(8):1720-1721.
[40] CHANTADA G,SCHAIQUEVICH P.Intra-arterial chemotherapy for retinoblastoma[J].JAMA Ophthalmol,2016,134(10):1202-1203.
相似文献/References:
[1]周朋义 彭广华.视网膜色素变性治疗的研究进展[J].眼科新进展,2012,32(5):000.
[2]杨红 阴正勤.眼球震颤的诊断与治疗研究进展[J].眼科新进展,2012,32(5):000.
[3]刘瑾 朱豫.视网膜母细胞瘤的治疗进展[J].眼科新进展,2013,33(1):000.
[4]邵毅 周琼 易昀敏 余瑶 裴重刚 吴晓蓉 梅峰 占敏艳.鬼针草叶治疗非增生型糖尿病视网膜病变的临床研究[J].眼科新进展,2013,33(6):000.
[5]杨世琳 杜改萍 郝玉华.频域OCT观察Vogt-小柳-原田病患者病程中黄斑中心凹的图像特点[J].眼科新进展,2013,33(6):000.
[6]曾春梅 文勇 成旋.特发性息肉样脉络膜血管病变的治疗进展[J].眼科新进展,2013,33(7):000.
[7]常海敏 杨磊 千新来.Calphostin C对人视网膜母细胞瘤细胞增殖的抑制作用[J].眼科新进展,2013,33(9):000.
[8]蒋永强 吴晓梅.眼睑皮脂腺癌治疗的研究进展[J].眼科新进展,2008,28(9):000.
[9]崔平 南娜 康洁 李军会 申景然.白藜芦醇对人视网膜母细胞瘤细胞侵袭能力的影响及机制研究[J].眼科新进展,2012,32(1):000.
[10]王玲 郑振优 邢健强.白内障摘出联合人工晶状体植入术治疗闭角型青光眼合并白内障临床疗效分析[J].眼科新进展,2012,32(9):000.
[11]吴沙,邹梦怡,廖洪斐.miRNA在视网膜母细胞瘤中的作用研究进展[J].眼科新进展,2022,42(1):071.[doi:10.13389/j.cnki.rao.2022.0016]
WU Sha,ZOU Mengyi,LIAO Hongfei.Advances in the role of microRNA in retinoblastoma[J].Recent Advances in Ophthalmology,2022,42(4):071.[doi:10.13389/j.cnki.rao.2022.0016]